Projects per year
Fingerprint
Dive into the research topics where Hendrik Everaert is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Finished
-
FWOAL468: Image-guided stereotactic radiotherapy for dose escalation in inoperable stage I/II non-small cell lung cancer with selective application of breathing synchronisation with audiovisual feedback.
Verellen, D., Storme, G., De Mey, J., Everaert, H., Meysman, M., Linthout, N. & Schallier, D.
1/01/08 → 31/12/11
Project: Fundamental
-
FWOAL390: Quantative measure of cancer treatment response using automated segmentation on volumetric and dynamic contrast enhanced CT-images in combination with pet.
Deklerck, R., Verellen, D., Storme, G., Nyssen, E. & Everaert, H.
1/01/06 → 31/12/09
Project: Fundamental
Research output
-
A comparison of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT with [18F]FDG-PET/CT in breast carcinoma patients.
Gondry, O., Xavier, C., Heemskerk, J., Raes, L. A. J., Debacker, J., De Geeter, F., Fontaine, C., Vanhoeij, M., Aspeslagh, S., Joris, S., De Grève, J., Verfaillie, G., Luyten, I., De Mey, L., Vandenbroucke, F., Waelput, W., Glorieus, K., Bourgeois, S., Cousaert, J., Vaneycken, I. & 5 others, , 2023.Research output: Unpublished contribution to conference › Unpublished abstract
-
A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB)
Schwarze, J. K., Geens, W., Tijtgat, J., Awada, G., Vanbinst, A., Everaert, H., Seynaeve, L., Michotte, A., Bruneau, M., VAN RIET, I., Tuyaerts, S., Duerinck, J. & Neyns, B., 3 Jun 2022.Research output: Unpublished contribution to conference › Poster
-
A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB)
Schwarze, J. K., Geens, W., Tijtgat, J., Awada, G., Seynaeve, L., Vanbinst, A-M., Everaert, H., Michotte, A., Bruneau, M., Van Riet, I., Tuyaerts, S., Duerinck, J. & Neyns, B., 1 Jun 2022, In: Journal of Clinical Oncology. 40, 16, 2033.Research output: Contribution to journal › Meeting abstract (Journal)
Open Access -
A PHASE I CLINICAL TRIAL ON THE INTRACRANIAL ADMINISTRATION OF INCREASING DOSES OF IPILIMUMAB PLUS FIXED DOSE NIVOLUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA (RGB)
Geens, W., Schwarze, J. K., Tijtgat, J., Lescrauwaet, L., Tuyaerts, S., Geeraerts, X., Stevens, L., Vanbinst, A-M., Everaert, H., Bruneau, M., Duerinck, J. & Neyns, B., Nov 2022, In: Neuro-oncology. 24, p. 62-62 1 p.Research output: Contribution to journal › Meeting abstract (Journal)
-
A phase I clinical trial on the intracranial administration of increasing doses of ipilimumab plus fixed dose nivolumab in patients with recurrent glioblastoma (rGB).
Geens, W., Schwarze, J. K., Tijtgat, J., Lescrauwaet, L. C., Tuyaerts, S., Geeraerts, X., Stevens, L., Vanbinst, A., Everaert, H., Bruneau, M., Duerinck, J. & Neyns, B., 2022.Research output: Unpublished contribution to conference › Poster
Prizes
-
Best Poster Award
Awada, Gil (Recipient), Özdemir, Ibrahim (Recipient), Schwarze, Julia Katharina (Recipient), Daeninck, E. (Recipient), Gondry, Odrade (Recipient), Jansen, Y. (Recipient), Seremet, T. (Recipient), Keyaerts, Marleen (Recipient), Everaert, Hendrik (Recipient) & Neyns, Bart (Recipient), 15 Dec 2018
Prize: Prize (including medals and awards)
Activities
-
A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB).
Wietse Geens (Speaker), Julia Katharina Schwarze (Contributor), Cleo Bertels (Contributor), Jens Tijtgat (Contributor), Gil Awada (Contributor), F Vaeyens (Contributor), Louise Cras (Contributor), Anne Vanbinst (Contributor), Hendrik Everaert (Contributor), Alex Michotte (Contributor), Toon Janssen (Contributor), Ben Caljon (Contributor), Thomas Cauwenbergh (Contributor), Michaël Bruneau (Contributor), Ramses Forsyth (Contributor), Sandra Tuyaerts (Contributor), Bart Neyns (Contributor) & Johnny Duerinck (Contributor)
26 Mar 2022Activity: Talk or presentation › Talk or presentation at a conference
-
Prognostic value of 0-(2-[18F]-fluoroethyl)-L-tyrosine PET in patients with recurrent glioblastoma.
Wietse Geens (Speaker), Stephanie Du Four (Contributor), S VAN LAERE (Contributor), Julia Katharina Schwarze (Contributor), Gil Awada (Contributor), Michaël Bruneau (Contributor), Jens Tijtgat (Contributor), Hendrik Everaert (Contributor), Bart Neyns (Contributor) & Johnny Duerinck (Contributor)
26 Mar 2022Activity: Talk or presentation › Talk or presentation at a conference
-
A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB).
Wietse Geens (Speaker), Julia Katharina Schwarze (Contributor), Cleo Bertels (Contributor), Jens Tijtgat (Contributor), Gil Awada (Contributor), F Vaeyens (Contributor), Louise Cras (Contributor), Anne Vanbinst (Contributor), Hendrik Everaert (Contributor), Alex Michotte (Contributor), Toon Janssen (Contributor), Ben Caljon (Contributor), Thomas Cauwenbergh (Contributor), Michaël Bruneau (Contributor), Ramses Forsyth (Contributor) & Bart Neyns (Contributor)
26 Mar 2022Activity: Talk or presentation › Talk or presentation at a conference
-
Intracranial administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in recurrent glioblastoma (rGB): a multi-cohort adaptive phase I clinical trial
Julia Katharina Schwarze (Speaker), Wietse Geens (Contributor), Jens Tijtgat (Contributor), Gil Awada (Contributor), Anne-Marie Van Binst (Contributor), Hendrik Everaert (Contributor), Laura Seynaeve (Contributor), Alex Michotte (Contributor), Michaël Bruneau (Contributor), I VAN RIET (Contributor), Sandra Tuyaerts (Contributor), Johnny Duerinck (Contributor) & Bart Neyns (Contributor)
16 Sep 2021 → 21 Sep 2021Activity: Talk or presentation › Talk or presentation at a conference
-
Hein Verberne
Hendrik Everaert (Host) & Sylvie De Raedt (Host)
5 Mar 2020Activity: Hosting a visitor › Hosting an academic visitor
Thesis
-
Early predictive and prognostic imaging biomarkers using FDG PET-CT in metastatic colorectal cancer under treatment
Author: Woff, E. & Everaert, H., 2016Student thesis: Doctoral Thesis
-
FDG PET/CT parameters voor de voorspelling van algemene en progressievrije overleving na pembrolizumab-behandeling bij melanoompatienten
Author: Özdemir, I., Keyaerts, M., Neyns, B. & Everaert, H., 20 Jun 2018Student thesis: Master's Thesis
-
Retrospectieve analyse van de waarde van totaal metabool tumor volume op FDG-PET/CT bij melanoompatiënten behandeld met Pembrolizumab
Author: Calliauw, L., Keyaerts, M., Neyns, B., Everaert, H. & Goethals, L., 13 Jun 2019Student thesis: Master's Thesis
-
Systematisch screenen voor infectie met een WBC-SPECT/CT na plaatsing van de elektrodes van een neurostimulator en voorafgaand aan het plaatsen van de permanente interne batterij, is dit zinvol?
Author: Vermeulen, S., Everaert, H., Goethals, L. & Keyaerts, M., 2016Student thesis: Master's Thesis